Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
Article in Rheumatology (March 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in Rheumatology (March 2024)
Article in JACC Basic to Translational Science (March 2024)
Preprint in Research Square (October 2023)